Private investors: FCPR

We apply our knowledge of French SMEs to help private investors who are looking for high-performance and meaningful investments

Private equity accessible to individual investors

  • Through its FCPR (“Fonds Communs de Placement à Risque”) range of private equity funds, Omnes Capital gives individual investors access to an asset class usually reserved for institutional investors.

Boost portfolio returns

  • Invest in unlisted SMEs that create wealth and employment
  • Diversify financial assets: recommended allocation for private equity - 5% of a portfolio
  • Achieve solid long-term performance: the class has outperformed the CAC 40 index by 5.2% over the past 10 years
  • Secure tax incentives: sales exempt from capital gains tax

Omnes’ expertise

  • 15 years’ experience
  • Rigorous selection of SMEs: high-performance French companies with a leadership position in their sector, genuine growth prospects, solid fundamentals and seasoned management team
  • Reasonable leverage and value creation underpinned by growth in portfolio companies net revenues
  • Strong entrepreneurial culture among management teams, who share the same vision as company executives
  • Direct access to the management team
  • Meetings with portfolio companies entrepreneurs and detailed reporting provided
Key figures
15
years’
experience
5
funds
dedicated to private investors
NewsRoom
Filters
Display:
Press release
09 May 2019
360 onlineprint enters British market after attracting an investment of 20.4 million dollars
360 onlineprint enters British market after attracting an investment of 20.4 million dollars
Press release
11 April 2019
NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance

NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance
Publication
Infrastructure Investor - Annual Review (March 2018)
II_AR-2017_v3.1.pdf
Press release
09 April 2019
Appointments within Omnes: Omnes welcomes five newcomers as Director, Principal, Analyst, Middle Office Managers, and promotes four Principals
Appointments within Omnes: Omnes welcomes five newcomers as Director, Principal, Analyst, Middle Office Managers, and promotes four Principals
Press release
03 April 2019
AgomAb Therapeutics Completes Euros 21m Series A Financing
AgomAb Therapeutics Completes Euros 21m Series A Financing
Press release
19 March 2019
Omnes announces a 15% investor net IRR on its Capenergie 2 fund, focused on renewable energy

Omnes announces a 15% investor net IRR on its Capenergie 2 fund, focused on renewable energy

Pages